S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ARTL Artelo Biosciences Inc

1.06

0.0145 (1.39%)

28 Dec 2024 - Closed

Delayed by 15 minutes

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

null

Artelo Biosciences (NASDAQ:ARTL)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Artelo Biosciences Charts.

Artelo Biosciences (NASDAQ:ARTL)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Artelo Biosciences Charts.

Artelo Biosciences Inc News

Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia
Tuesday 10 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
Tuesday 19 November 2024 (1 month ago) • GlobeNewswire Inc.

Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium
Thursday 14 November 2024 (1 month ago) • GlobeNewswire Inc.

Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program
Wednesday 6 November 2024 (2 months ago) • GlobeNewswire Inc.

Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th
Thursday 10 October 2024 (3 months ago) • GlobeNewswire Inc.

Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Wednesday 4 September 2024 (4 months ago) • GlobeNewswire Inc.

Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
Tuesday 13 August 2024 (5 months ago) • GlobeNewswire Inc.

Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor
Monday 15 July 2024 (5 months ago) • GlobeNewswire Inc.

Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium
Wednesday 3 July 2024 (6 months ago) • GlobeNewswire Inc.

Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform
Tuesday 2 July 2024 (6 months ago) • GlobeNewswire Inc.

More Artelo Biosciences Inc News Articles

JP Morgan Chase

Newcrest Mining

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions